Beta Bionics, Inc. (BBNX) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income -$25.58M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income -$24.27M; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income -$17.04M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income -$19.87M; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | Reported | (m) | -$25.58M | (m) | $32.01M | (m) | $1.04M* | -$14.62M* | $13.11M | $10.24M | (m) | (m) |
| 2026-03-31 | Reported | (m) | -$24.27M | (m) | $27.63M | (m) | $1.38M | -$23.83M | $11.19M | $10.36M | (m) | (m) |
| 2025-09-30 | Reported | (m) | -$17.04M | (m) | $27.25M | (m) | $1.28M* | -$8.73M* | $12.13M | $8.20M | (m) | (m) |
| 2025-06-30 | Reported | (m) | -$19.87M | (m) | $23.24M | (m) | $1.78M* | -$13.59M* | $10.73M | $8.87M | (m) | (m) |
| 2025-03-31 | Reported | (m) | -$18.64M | (m) | $17.64M | (m) | $333.00K | -$19.98M | $8.67M | $7.59M | (m) | (m) |
| 2024-09-30 | Reported | (m) | -$10.98M | (m) | $16.70M | (m) | $1.92M* | -$9.61M* | $7.79M | $5.14M | (m) | (m) |
| 2024-06-30 | Reported | (m) | -$11.78M | (m) | $15.05M | (m) | $507.00K* | -$12.24M* | $6.96M | $6.35M | (m) | (m) |
| 2024-03-31 | Reported | (m) | -$9.45M | (m) | $12.93M | (m) | $406.00K | -$12.14M | $5.73M | $5.48M | (m) | (m) |
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | Reported | (m) | -$71.68M | (m) | $100.25M | (m) | $5.30M | -$50.92M | $44.71M | $34.79M | (m) | $0.00 |
| 2024-12-31 | Reported | (m) | -$45.25M | (m) | $65.12M | (m) | $3.40M | -$48.27M | $29.24M | $26.18M | (m) | $0.00 |
| 2023-12-31 | Reported | (m) | -$35.85M | (m) | $11.99M | (m) | $402.00K | -$32.45M | $5.69M | $17.94M | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |